Human embryonic stem cell-derived mesenchymal stromal cells.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3261503)

Published in Transfusion on November 01, 2011

Authors

Peiman Hematti1

Author Affiliations

1: Department of Medicine, Division of Hematology/Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin 53705-2275, USA. pxh@medicine.wisc.edu

Articles cited by this

Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19

Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55

Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (2008) 12.59

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood (2002) 9.40

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62

Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol (2007) 6.63

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82

Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation (1968) 5.52

HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35

Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol (2005) 5.31

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol (2003) 4.62

Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood (2001) 4.22

Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells (2004) 3.98

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol (2007) 3.87

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant (2002) 3.24

Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 3.07

Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med (2005) 3.04

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells (2004) 2.88

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant (2005) 2.82

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis (2010) 2.64

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation (2003) 2.49

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood (2002) 2.43

Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant (1995) 2.35

Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells (2010) 2.25

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes (2008) 2.25

Mesenchymal stem cells: progress toward promise. Cytotherapy (2005) 2.19

Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells (2006) 2.11

Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell (2010) 2.10

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2005) 1.93

Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells (2006) 1.92

Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells (2009) 1.91

Mesenchymal stromal cells. Curr Opin Hematol (2006) 1.88

Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells (2003) 1.88

Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation (2005) 1.85

Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy (2009) 1.81

Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol (2008) 1.80

Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells (2004) 1.74

Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng (2006) 1.72

In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells (2003) 1.67

Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood (2006) 1.63

In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59

Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci (2004) 1.56

Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A (2010) 1.52

An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells (2005) 1.49

Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol (2007) 1.40

Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells (2005) 1.38

Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg (2008) 1.38

Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy (2009) 1.35

Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells (2011) 1.27

Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells (2007) 1.25

Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) (2008) 1.17

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia (2007) 1.16

Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol (2007) 1.14

Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg (1999) 1.14

Cell therapy approaches for lung diseases: current status. Curr Opin Pharmacol (2009) 1.13

Human embryonic stem cell and embryonic germ cell lines. Trends Biotechnol (2000) 1.10

Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells (2009) 1.07

OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs (2006) 1.07

Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol (2007) 1.02

Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell (2005) 1.02

Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells (2005) 1.01

Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther (2006) 0.97

Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells (2006) 0.97

Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation (2009) 0.96

Osteogenic nodule formation from single embryonic stem cell-derived progenitors. Stem Cells Dev (2006) 0.86

Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol (2008) 0.86

Embryonic stem cells for osteo-degenerative diseases. Methods Mol Biol (2011) 0.84

Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol (2011) 0.82

Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy (2007) 0.79

FDA to vet embryonic stem cells' safety. Nature (2008) 0.75